Sandu Pharmaceuticals Balance Sheet Annual

BSE: 524703 | NSE: - | ISIN: INE751D01014 | Sector: Biotechnology & Drugs

57.82 +0.02 (0.03%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	1.00	2.28	0.94	4.53
Short Term Investments	0.20	0.02	3.23	7.13
Cashand Short Term Investments	1.21	2.30	4.17	11.66
Accounts Receivable- Trade Net	4.87	4.79	3.99	5.35
Total Receivables Net	4.87	4.79	3.99	5.35
Total Inventory	12.25	14.33	11.27	11.14
Other Current Assets Total	3.98	4.13	4.21	2.40
Total Current Assets	22.30	25.55	23.65	30.54
Property/ Plant/ Equipment Total- Net	17.84	16.99	16.45	16.11
Intangibles Net	0.03	0.05	0.03	0.07
Long Term Investments	12.23	11.58	9.15	0.25
Other Long Term Assets Total	0.00	0.00	0.00	0.00
Total Assets	52.41	54.17	49.28	46.96
Accounts Payable	4.20	8.40	6.82	6.67
Current Portof LT Debt/ Capital Leases	0.00	-	-	-
Other Currentliabilities Total	6.45	5.49	5.06	5.83
Total Current Liabilities	10.64	13.88	11.87	12.52
Capital Lease Obligations	0.06	-	-	-
Total Long Term Debt	0.06	0.00	0.00	0.00
Total Debt	0.06	0.00	0.00	0.02
Deferred Income Tax	1.12	1.04	0.94	0.95
Total Liabilities	11.82	14.93	12.81	13.47
Common Stock Total	9.66	9.66	8.81	7.92
Retained Earnings( Accumulated Deficit)	30.93	29.58	27.66	25.57
Total Equity	40.59	39.24	36.47	33.49
Total Liabilities Shareholders' Equity	52.41	54.17	49.28	46.96
Total Common Shares Outstanding	0.97	0.97	0.88	0.79
Tangible Book Valueper Share Common Eq	41.98	40.57	41.36	42.20
Notes Payable/ Short Term Debt	-	0.00	0.00	0.02
Other Equity Total	-	0.00	0.00	-
Note Receivable- Long Term	-	-	-	0.00
Other Liabilities Total	-	-	-	0.00